Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
1998

TP53 Mutations and Breast Cancer Outcomes

Sample size: 222 publication Evidence: moderate

Author Information

Author(s): EMJJ Berns, IL van Staveren, MP Look, M Smid, JGM Klijn, JA Foekens

Primary Institution: Rotterdam Cancer Institute (Daniel den Hoed Kliniek)/University Hospital Rotterdam

Hypothesis

Mutations in the TP53 gene that directly contact DNA predict poor outcomes in breast cancer patients.

Conclusion

The study found that TP53 mutations, particularly those affecting DNA contact residues, are associated with poorer relapse-free survival in breast cancer patients.

Supporting Evidence

  • TP53 mutations were found in 31% of the breast cancer specimens analyzed.
  • Missense mutations accounted for 78% of the observed TP53 mutations.
  • Patients with TP53 mutations had a median relapse-free survival of 34 months compared to 48 months for those without mutations.

Takeaway

This study shows that changes in a specific gene called TP53 can make breast cancer worse, especially if the changes happen in parts of the gene that touch DNA.

Methodology

The study analyzed TP53 gene mutations in 222 breast cancer specimens using PCR-SSCA and sequencing.

Limitations

The study excluded 45 patients due to unknown tumor characteristics or insufficient follow-up.

Participant Demographics

The study involved 222 female breast cancer patients with a median age of 59 years.

Statistical Information

P-Value

P = 0.02

Confidence Interval

95% CI: 1.1-2.4

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication